Compare GPRE & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPRE | AHG |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Business Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 812.2M | 757.9M |
| IPO Year | 2004 | 2017 |
| Metric | GPRE | AHG |
|---|---|---|
| Price | $13.58 | $1.31 |
| Analyst Decision | Hold | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $10.61 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 5.1K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,091,680,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $30.18 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.14 | $0.83 |
| 52 Week High | $15.64 | $2.10 |
| Indicator | GPRE | AHG |
|---|---|---|
| Relative Strength Index (RSI) | 58.60 | 40.25 |
| Support Level | $13.12 | $1.25 |
| Resistance Level | $15.64 | $1.45 |
| Average True Range (ATR) | 0.97 | 0.11 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 55.41 | 17.14 |
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.